Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
19 July 2021

The Faculty of Economic and Management Sciences invites all its academic departments to participate in the 2021 celebration of Nelson Mandela Day by requesting their staff and students to become involved in a 67-minute fitness challenge to be held over a seven-day period, commencing on 18 July 2021. These kilometres can be completed by running, walking, swimming or on a bicycle (no vehicles permitted). 

These activities may be completed at any location, at any time from 18 to 25 July 2021 (terminating at midnight on 25 July). This ensures that social distancing protocols are adhered to, since each individual is completing the challenge on their own.

Participants will be required to provide relevant proof of the distance completed, as well as the date and time interval, by either submitting a picture of the treadmill screen, sharing the progress they logged by using a mobile app such as Strata, pictures of the number of steps completed, etc. (Send this via email to Reabetswe Parkies at Parkiesrg@ufs.ac.za upon completion – at the latest by 08:00 on 26 July 2021.)

Raising funds

To raise funds, each department in the faculty is requested to consider sponsoring a specific amount per kilometre completed by their staff and students. It is recommended that each department consider its available budget for this purpose and that the total departmental contribution should be capped at a specific amount to ensure that departments are not faced with open-ended liabilities.  We have sought and obtained approval from the Department of Finance for the use of UFS funds in this manner. To this end, for example, the School of Accountancy has pledged to contribute R10 per kilometre completed, capped at a maximum contribution of R6 700.

To encourage healthy competition and to increase the amount raised, departments will be encouraged to compete against each other and attempt to complete the most kilometres. Each department will donate their pledges to the charity of their choice.  In support of this noble cause, the Dean’s office has pledged a donation of R6 700 to the winning academic department, to be added to the department’s donation to the charity. 

We believe this is a very good marketing initiative, as well as an opportunity for the faculty to illustrate its commitment to social investment and community engagement.  It is also likely to contribute to improving the morale of the staff in the faculty. The UFS Community Engagement office has further indicated that it would like to arrange a radio interview to promote this event – to this end, we can raise awareness and place the spotlight on a worthy cause.

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept